BrainsWay Ltd. (BWAY)
NASDAQ: BWAY · IEX Real-Time Price · USD
4.870
+0.080 (1.67%)
At close: Apr 19, 2024, 4:00 PM
4.960
+0.090 (1.85%)
After-hours: Apr 19, 2024, 4:39 PM EDT
Company Description
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally.
It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases.
The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.
BrainsWay Ltd.
| Country | Israel |
| Founded | 2003 |
| IPO Date | Apr 17, 2019 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 134 |
| CEO | Hadar Levy |
Contact Details
Address: 50 Rowes Wharf 6th Fl Boston, Massachusetts 02110 United States | |
| Phone | 6179603400 |
| Website | brainsway.com |
Stock Details
| Ticker Symbol | BWAY |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $11.00 |
| CIK Code | 0001076643 |
| CUSIP Number | 10501L106 |
| ISIN Number | US10501L1061 |
| Employer ID | 04-3285165 |
| SIC Code | 7389 |
Key Executives
| Name | Position |
|---|---|
| Hadar Levy | Chief Executive Officer |
| Avner Hagai | Founder and Director |
| Prof. Abraham Zangen | Co-Founder, Member of Scientific Advisory Board and Director |
| Christopher J. Boyer Ph.D. | Vice President of Global Marketing |
| Dr. Yiftach Roth Ph.D. | Founder and Chief Scientific Officer |
| Ido Marom | Chief Financial Officer |
| Menachem C. Klein Esq. | Vice President, General Counsel and Corporate Secretary |
| Dr. Aron Tendler | Chief Medical Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 10, 2010 | REVOKED | Filing |
| Sep 10, 2001 | 4 | Statement of changes in beneficial ownership of securities |
| Sep 5, 2001 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| Sep 5, 2001 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| Sep 5, 2001 | 8-K | Current Report |
| Aug 15, 2001 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB |
| Aug 8, 2001 | 4 | Statement of changes in beneficial ownership of securities |
| Aug 8, 2001 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| Jul 5, 2001 | 10-K | Annual Report |
| Jun 27, 2001 | 8-K | Current Report |